76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Faes Farma SA
Closed
4.475 0.11
Overview
Share price change
24h
Min
4.47
Max
4.5
Income | 32M 53M |
|---|---|
Sales | 98M 232M |
P/E Sector Avg | 12.556 50.291 |
Dividend yield | 1.81 |
Profit margin | 22.798 |
Employees | 1,775 |
EBITDA | 6.5M 49M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +22.77% upside |
Dividend yield Sector Avg | 1.81% 2.40% |
|---|---|
Next Earnings | 29 Jul 2025 |
Market Cap | 96M 1.4B |
|---|---|
Previous open | 4.36 |
Previous close | 4.475 |
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Faes Farma SA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Faes Farma SA Forecast
Price Target
By TipRanks
22.77% upside
12 Months Forecast
Average 5.5 EUR 22.77%
High 5.5 EUR
Low 5.5 EUR
Based on 1 Wall Street analysts offering 12 month price targets forFaes Farma SA - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
